|
| 1 |
Robotic assisted cytoreductive surgery, removal of a recurrent disease in the right pericaval lymph node in a patient with ovarian cancer with the robotic Xi platform
Massoud Shoraka, Hadeer Metwally, Semiramis Carbajal-Mamani, Joel Cardenas-Goicoechea
Obstet Gynecol Sci.2021;64(6):560-564. Published online 2021 August 13
DOI: http://dx.doi.org/10.5468/ogs.21202
|
|
| 2 |
Treatment options for advanced gastric cancer with peritoneal metastasis: experience from a single institution in Korea
Dong-Wook Kim, Sang Il Youn, Ye Seob Jee
|
|
| 3 |
Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca
|
|
| 4 |
Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely
Kyoko Nishikimi, Shinichi Tate, Kazuyoshi Kato, Ayumu Matsuoka, Makio Shozu
|
|
| 5 |
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
Ying L. Liu, Olga T. Filippova, Qin Zhou, Alexia Iasonos, Dennis S. Chi, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner, Vance A. Broach, Roisin E. O'Cearbhaill, Jason A. Konner, Carol Aghajanian, Kara Long Roche, William P. Tew
|
|
| 6 |
The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
Makiko So, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
|
|
| 7 |
Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yutaka Yoneoka, Mitsuya Ishikawa, Takashi Uehara, Hanako Shimizu, Masaya Uno, Takashi Murakami, Tomoyasu Kato
|
|
| 8 |
Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo Morotti
|
|
| 9 |
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
Giorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Diito, Fabio Martinelli, Domenica Lorusso, Francesco Raspagliesi
|
|
| 10 |
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone, Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
|
|
| 11 |
Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study
Alaa A. Elzarkaa, Waleed Shaalan, Doaa Elemam, Hassan Mansour, Mahmoud Melis, Eduard Malik, Amr A. Soliman
|
|
| 12 |
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
|
|
| 13 |
Diagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
Young-Jae Lee, Yong-Man Kim, Phill-Seung Jung, Jong-Jin Lee, Jeong-Kon Kim, Young-Tak Kim, Joo-Hyun Nam
|
|
| 14 |
Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
|
|
| 15 |
Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
Haruko Iwase, Toshio Takada, Chiaki Iitsuka, Hidetaka Nomura, Akiko Abe, Tomoko Taniguchi, Ken Takizawa
|
|
| 16 |
Role of aggressive surgical cytoreduction in advanced ovarian cancer
Suk-Joon Chang, Robert E. Bristow, Dennis S. Chi, William A. Cliby
|
|
